Khosla Ventures doubles down on Even Healthcare to challenge India’s hospital economics

Hospital costs for patients in India will likely decrease as Even Healthcare scales its outcome-focused model.

Even Healthcare, an Indian startup, has secured $50 million in a Series B funding round led by Khosla Ventures, with participation from Alpha Wave. This funding values the company at $300 million and brings its total raised capital to over $120 million. Even Healthcare aims to reform the Indian hospital business model, which traditionally incentivizes longer patient stays and more procedures. The company focuses on patient care outcomes rather than increased service utilization, aligning with investor Vinod Khosla's vision of a new healthcare model. Even is building and operating its own hospitals, having already opened two in Bengaluru that achieved profitability within a year. The startup plans to expand by opening five more hospitals in Bengaluru soon. Even Healthcare's model includes paying doctors fixed salaries and offering equity to all employees, including doctors and management, to align incentives with long-term performance and patient well-being, not just revenue generation. Despite a net loss of $9.50 million in fiscal year 2025 and recent layoffs, the company is prioritizing growth and plans for profitability in the near future.

Even Healthcare's shift from relying on partner hospitals to building its own facilities marks a significant strategic pivot, driven by a desire for greater control over care quality and cost. This move allows them to directly implement their compensation structures, which reward better patient outcomes rather than procedure volume, and embed equity ownership across their workforce to foster a culture aligned with long-term health results. The company's impressive claim of a sub-1% unplanned readmission rate, compared to industry benchmarks of 8-15%, suggests a potential for dramatically improved efficiency and patient satisfaction.

The sustained investment from Khosla Ventures, including a doubling down from their seed investment, signals strong conviction in Even Healthcare's disruptive potential within the vast Indian healthcare market. By integrating financing, technology, and direct care delivery, Even aims to establish a scalable model that could fundamentally challenge the existing hospital economics, not only in India but potentially in other emerging markets. Investors will be watching closely to see if Even can navigate its current losses and expansion plans to achieve profitability while proving the long-term viability and replicability of its patient-centric approach.